Kobe, Japan

Mayumi Sugimoto

This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Sysmex Corporation. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mayumi Sugimoto. Retrieved from https://idiyas.com/inventor/mayumi-sugimoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 4.2

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mayumi Sugimoto: Innovator in Monoclonal Antibody Development

Introduction

Mayumi Sugimoto is a prominent inventor based in Kobe, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 2 patents, her work has the potential to impact medical diagnostics and treatment.

Latest Patents

Sugimoto's latest patents include the "Anti-FDP monoclonal antibody, FDP measurement reagent and reagent kit using same, and FDP measurement method." This invention relates to an anti-FDP monoclonal antibody selected from three different monoclonal antibodies that exhibit varying reactivity towards FDP. Additionally, she has developed a reagent and reagent kit for measuring FDP, along with a method for measurement utilizing these antibodies. Another patent focuses on a reagent for FDP measurement that includes a carrier sensitized with at least two monoclonal antibodies selected from three, enhancing the accuracy of FDP measurement.

Career Highlights

Mayumi Sugimoto is currently associated with Sysmex Corporation, a company known for its innovative solutions in laboratory diagnostics. Her role at Sysmex has allowed her to further her research and development efforts in the field of monoclonal antibodies.

Collaborations

Throughout her career, Sugimoto has collaborated with notable colleagues, including Katsushi Kobayashi and Masumi Murakami. These collaborations have contributed to her success and the advancement of her research projects.

Conclusion

Mayumi Sugimoto's work in the development of monoclonal antibodies showcases her innovative spirit and dedication to improving medical diagnostics. Her contributions are poised to make a lasting impact in the field of biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…